Idelalisib
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 806 publications
Cyclodextrin-Mediated Enantiomeric Separation of Idelalisib: A Validated Capillary Electrophoresis and NMR Study.
Journal: International journal of molecular sciences
Published: May 06, 2026
Refractory Thrombocytopenia in TP53-Aberrant Chronic Lymphocytic Leukemia: A Multimechanistic Case with Response to Idelalisib and Romiplostim.
Journal: Journal of clinical medicine
Published: April 28, 2026
Utility of mouse precision cut lung slices as an in vitro model for interrogating the lung immune response against bacterial pathogens in the context of immunomodulatory therapeutics.
Journal: Respiratory research
Published: April 02, 2026
Sex-Specific Safety Profiles of PI3K Inhibitors: A Real-World Pharmacovigilance Study Based on FAERS Database.
Journal: Clinical therapeutics
Published: March 18, 2026
The Impact of the BCR Phenotype of Large B-cell Lymphoma on Ibrutinib Sensitivity.
Journal: Anticancer research
Published: March 01, 2026
Targeting PI3Kδ for lymphoma and immune diseases treatment: a review.
Journal: Molecular diversity
Published: January 20, 2026
Integrated Transcriptomic and Secretome Proteomic Analysis of Hyperglycemia-Stimulated Endothelial Cells and Screening of Target Compounds.
Journal: Journal of visualized experiments : JoVE
Published: January 19, 2026
Drug-induced eosinophilic pneumonia: a real-world data mining study of the FAERS and Vigibase database reveals potential safety signals and risk patterns.
Journal: Frontiers in medicine
Published: January 15, 2026
Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in Italy.
Journal: Hematological oncology
Published: December 17, 2025
Dual PI3Kδ/γ inhibition enhances radiotherapy-induced antitumor immunity via macrophage-dependent cGAS-STING-type I interferon signaling.
Journal: Biochemical and biophysical research communications
Published: December 01, 2025
A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL-321.
Journal: British journal of haematology
Published: November 13, 2025
Evaluation of the Role of AID-Induced Mutagenesis in Resistance to B-Cell Receptor Pathway Inhibitors in Chronic Lymphocytic Leukemia.
Journal: Current issues in molecular biology
Published: November 13, 2025
Last Updated: 09/26/2026